Karen Duff
Impact in
- Physiology top 0.01%
- Alzheimer's disease research and treatments
- Neurology top 0.05%
- Neuroinflammation and Neurodegeneration Mechanisms
- Parkinson's Disease Mechanisms and Treatments
Papers in
-
- Neuroscience and Neuropharmacology Research 40
- Genetic Neurodegenerative Diseases 37
- Nuclear Receptors and Signaling 24
- Physiology 143
- Alzheimer's disease research and treatments 141
- Co-authors
- John HardyScott A. SmallJohn J. LaFrancoisLeigh J. BeglingerJane S. PaulsenWai Haung YuMarcia N. GordonDouglas R. Langbehn
- Journals
- Neurobiology of Disease (12 papers)Journal of Neuroscience (12 papers)Archives of Clinical Neuropsychology (11 papers)Nature Neuroscience (7 papers)Alzheimer s & Dementia (7 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Karen Duff
233 papers receiving 29.0k citations
Hit Papers
Peers
Comparison fields: 5 of 177
- Physiology 18.0k
- Neurology 5.2k
- Cellular and Molecular Neuroscience 9.6k
- Biological Psychiatry 1.1k
- Neurology 4.5k
Countries citing papers authored by Karen Duff
This map shows the geographic impact of Karen Duff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Duff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Duff more than expected).
Fields of papers citing papers by Karen Duff
This network shows the impact of papers produced by Karen Duff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Duff. The network helps show where Karen Duff may publish in the future.
Co-authors
The 25 scholars most cited alongside Karen Duff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 3 | |
| 3 | 2022 | 32 | |
| 4 | 2021 | 74 | |
| 5 | 2021 | 26 | |
| 6 | 2021 | 5 | |
| 7 | 2020 | 18 | |
| 8 | 2020 | 49 | |
| 9 | Selective vulnerability in neurodegenerative diseases Hit paper breakdown → | 2018 | 354 |
| 10 | 2018 | 167 | |
| 11 | 2017 | 134 | |
| 12 | 2012 | 408 | |
| 13 | 2010 | 141 | |
| 14 | 2010 | 9 | |
| 15 | 2010 | 284 | |
| 16 | 2009 | 133 | |
| 17 | 2009 | 333 | |
| 18 | 2001 | 19 | |
| 19 | APOLIPOPROTEIN-E GENOTYPE AND ALZHEIMERS-DISEASE | 1993 | 246 |
| 20 | CONFIRMATION THAT THE APOLIPOPROTEIN E4 ALLELE IS ASSOCIATED WITH LATE-ONSET, FAMILIAL ALZHEIMERS-DISEASE | 1993 | 6 |
About Karen Duff
Karen Duff is a scholar working on Cellular and Molecular Neuroscience, Physiology, Neurology, Neurology and Psychiatry and Mental health, having authored 236 papers that have together received 29.5k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (141 papers), Neuroscience and Neuropharmacology Research (40 papers), Genetic Neurodegenerative Diseases (37 papers), Prion Diseases and Protein Misfolding (29 papers), Neurological disorders and treatments (25 papers), Nuclear Receptors and Signaling (24 papers), Cholinesterase and Neurodegenerative Diseases (21 papers) and Computational Drug Discovery Methods (20 papers). The work is most often cited by research in Physiology (18.0k citations), Neurology (5.2k citations), Cellular and Molecular Neuroscience (9.6k citations), Biological Psychiatry (1.1k citations) and Neurology (4.5k citations). Karen Duff has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include John Hardy, Scott A. Small, John J. LaFrancois, Leigh J. Beglinger, Jane S. Paulsen, Wai Haung Yu, Marcia N. Gordon, Douglas R. Langbehn, Jessica Wu and Peter Davies. Their work appears in journals such as Neurobiology of Disease, Journal of Neuroscience, Archives of Clinical Neuropsychology, Nature Neuroscience and Alzheimer s & Dementia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.